title: [AIAC Guidelines on the management and treatment of atrial fibrillation. Update 2013. Associazione Italiana di Aritmologia e Cardiostimolazione].
authors.affiliation: Alleanza per la Lotta alla Fibrillazione Atriale - ALFA, Via Torino 151/c, 30171 Mestre-Venezia. araviele@tin.it
authors.forename: Antonio
authors.initials: A
authors.lastname: Raviele
authors.forename: Marcello
authors.initials: M
authors.lastname: Disertori
authors.forename: Paolo
authors.initials: P
authors.lastname: Alboni
authors.forename: Emanuele
authors.initials: E
authors.lastname: Bertaglia
authors.forename: Gianluca
authors.initials: G
authors.lastname: Botto
authors.forename: Michele
authors.initials: M
authors.lastname: Brignole
authors.forename: Riccardo
authors.initials: R
authors.lastname: Cappato
authors.forename: Alessandro
authors.initials: A
authors.lastname: Capucci
authors.forename: Maurizio
authors.initials: M
authors.lastname: Del Greco
authors.forename: Roberto
authors.initials: R
authors.lastname: De Ponti
authors.forename: Matteo
authors.initials: M
authors.lastname: Di Biase
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Di Pasquale
authors.forename: Michele
authors.initials: M
authors.lastname: Gulizia
authors.forename: Federico
authors.initials: F
authors.lastname: Lombardi
authors.forename: Sakis
authors.initials: S
authors.lastname: Themistoclakis
authors.forename: Massimo
authors.initials: M
authors.lastname: Tritto
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D017115:Catheter Ablation; D019468:Disease Management; D004359:Drug Therapy, Combination; D004554:Electric Countershock; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D006339:Heart Rate / Q000187:drug effects; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D055502:Secondary Prevention; D055989:Septal Occluder Device; D015607:Stents; D019851:Thrombophilia / Q000188:drug therapy / Q000209:etiology
chemical_list: D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D015525:Fatty Acids, Omega-3; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors